FINANCIAL GURKHA BLOGS
Federal Reserve Keeps Interest Rates Steady
The Federal Open Market Committee left the target range for the federal funds rate at 3.5 percent to 3.75 percent. The headline says "Fed holds." The headline is the least interesting sentence in the document.
All About Monad (MON): Generate Value From Monad Blockchain
MON is the native-token of Monad Blockchain, an EVM comatible L1,the all-new superfast 10,000 TPS blockchain making waves. Learn all about Monad Blockchain, MON tokens, and how to gain value and make money from the Monad blockchain and its native MON tokens.
An Intrinsic Valuation of FIGMA (NYSE:FIG)
Figma just crossed the $1bn annual revenue mark and maintains a 40% growth rate. Let's dive deep into Figma's filings and estimate an intrinstic value of the leading collaborative design platform for building meaningful products
America's Net Investment Position with the World
How much of American assets does the world own? How much global stocks does America own? We expand the scope of Bureau of Economic Analysis to understand America's net investment position with the world.
Dollar Gold Crude Relations
Making sense of the relationship between the US Dollar, Gold, and Crude Petroleum.
Gold: A Primer on Commodities and Trading
Commodity traders believe we are in the midst of a commodities market supercycle - a period of more 6 years where commodities priced in USD are going to see significant rise in their prices. Gold and Silver are amongst the most traded precious metal commodities. In this article, we explore Gold, the most widely coveted precious metal.
Novo Nordisk DCF Valuation: Should you invest in the Ozempic and Wegovy Maker for exeptional returns?
Novo Nordisk briefly became Europe’s most valuable company by market cap before experiencing a sharp 60% pullback within six months. Despite the volatility, this century-old pharmaceutical leader continues to innovate across its core specialties in diabetes and blood-related disorders. The company is aggressively scaling its production capacity for high-demand treatments while investing heavily in research aimed at curing emerging diseases. Novo Nordisk’s international revenue segments and its growing online prescription platform are also delivering strong year-over-year growth. In this analysis, we break down Novo Nordisk’s fundamentals and present a full intrinsic valuation using DCF.
MP Materials Valuation: A Discounted Cash Flow Approach
MP Materials (NYSE:MP), a leading rare earth materials producer in the Western Hemisphere, has impressively grown their revenue since going public in 2020. The company recently began producing NdPr - core ingredients for manufacturing permanent magnets. In this article we approach MP Materials valuation through a discounted cash flow approach.